Nostrilla
NDC Package 63736-072-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Nostrilla is do not exceed 2 doses in any 24 hour periodadults and children 6 to under 12 years of age (with adult supervision)2 or 3 sprays in each nostril not more often than every 10 to 12 hours.children under 6 years of ageask a doctor. Marketed by Insight Pharmaceuticals, this product is identified by NDC 63736-072 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
63736-072-01
Package Description
1 BOTTLE, SPRAY in 1 CARTON / 15 mL in 1 BOTTLE, SPRAY
Product Code
11-Digit Billing Format
63736007201
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Nostrilla
Dosage Form
-
Usage Information
Do not exceed 2 doses in any 24 hour periodadults and children 6 to under 12 years of age (with adult supervision)2 or 3 sprays in each nostril not more often than every 10 to 12 hours.children under 6 years of ageask a doctor

Regulatory & Marketing

Labeler Name
Insight Pharmaceuticals
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
06-08-2009
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63736-072-01 identifies a specific commercial package of 1 bottle, spray in 1 carton / 15 ml in 1 bottle, spray of Nostrilla, labeled by Insight Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Insight Pharmaceuticals on June 08, 2009. The current certification is valid through December 31, 2017.

How is this Insight Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63736007201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63736-072-01
11-Digit CMS (5-4-2)
63736-0072-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.